1. Lee, P.N., Epidemiological evidence relating snus to health – an updated review based on recent publications. Harm Reduction Journal, 2013.
2. Hajat, C., et al., The health impact of smokeless tobacco products: a systematic review. Harm reduction journal, 2021.
3. Folkehelseinstituttet. Historisk oversikt over tobakk i Norge 1619-2021.
4. Statistisk Sentralbyrå. Færre røykere, flere snusere. 2020
5. Benowitz, N.L., Pharmacokinetic considerations in understanding nicotine dependence. Ciba Foundation Symposium, 1990.
6. Barrett, S.P., The effects of nicotine, denicotinized tobacco, and nicotine-containing tobacco on cigarette craving, withdrawal, and self-administration in male and female smokers. Behavourial Pharmacology, 2010.
7. Fagerström & Eissenberg, Dependence on tobacco and nicotine products: a case for product-specific assessment. Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 2012.
8. Byhamre et al., Swedish snus use is associated with mortality: a pooled analysis of eight prospective studies. Int J Epidemiol, 2021.
9. Vist et al. Er helserisikoen ved snus undervurdert? Tidsskriftet for Den Norske Legeforening, 2020.
10. Levy et al., The relative risks of a low-nitrosamine smokeless tobacco product compared with smoking cigarettes: estimates of a panel of experts. Cancer Epidemiology, Biomarkers and Prevention, 2004.
11. Nutt et al., Estimating the harms of nicotine-containing products using the MCDA approach. Eur Addict Res, 2014.
12. Corkery et al., Two UK suicides using nicotine extracted from tobacco employing instructions available on the Internet. Forensic Sci Int, 2010.
13. Mayer, B., How much nicotine kills a human? Tracing back the generally accepted lethal dose to dubious self-experiments in the nineteenth century. Archives of toxicology, 2014.
14. Smokeless tobacco and some tobacco-specific N-nitrosamines. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, 2007.
15. Lee, P.N., Summary of the epidemiological evidence relating snus to health. Regul Toxicol Pharmacol, 2011.
16. Asthana et al., Association of Smokeless Tobacco Use and Oral Cancer: A Systematic Global Review and Meta-Analysis. Nicotine and Tobacco Research, 2019.
17. Carlsson et al., Smokeless tobacco (snus) is associated with an increased risk of type 2 diabetes: results from five pooled cohorts. J Intern Med, 2017.
18. Bajaj, M., Nicotine and insulin resistance: when the smoke clears. Diabetes, 2012.
19. Grant et al., Nicotine Use and DSM-IV Nicotine Dependence in the United States, 2001-2002 and 2012-2013. Am J Psychiatry, 2020.
20. Post et al., Symptoms of nicotine dependence in a cohort of Swedish youths: a comparison between smokers, smokeless tobacco users and dual tobacco users. Addiction, 2010.
21. Watkins et al., Neural mechanisms underlying nicotine addiction: acute positive reinforcement and withdrawal. Nicotine Tob Res, 2000.
22. Dybing & Sanner, Nikotinavhengighet – medisinsk-biologiske forhold. Tidsskriftet for Den Norske Legeforening, 2002.
23. Hughes et al., Nicotine withdrawal versus other drug withdrawal syndromes: similarities and dissimilarities. Addiction, 1994.
24. Munafo et al., Snus use and risk of schizophrenia and non-affective psychosis. Drug and Alcohol Dependence, 2016.
25. King et al. Cigarette smoking as a risk factor for schizophrenia or all non-affective psychoses. Psychological Medicine, 2020.
26. Russell M.A.H., Subjective and behavioural effects of nicotine in Humans: some sources of individual variation. Progress in Brain Research, 1989.